List Name |
Annotation |
Enrichment |
p-value |
mitochondrial membrane organization and biogenesis |
AmiGO Browser |
28.90 |
2.21e-03 |
germ cell development |
AmiGO Browser |
23.12 |
3.44e-03 |
cell cycle phase |
AmiGO Browser |
4.27 |
6.95e-03 |
mitochondrion organization and biogenesis |
AmiGO Browser |
12.84 |
0.01 |
receptor-mediated endocytosis |
AmiGO Browser |
11.24 |
0.01 |
M phase |
AmiGO Browser |
4.32 |
0.01 |
regulation of cell growth |
AmiGO Browser |
5.86 |
0.02 |
protein import into mitochondrial inner membrane |
AmiGO Browser |
57.79 |
0.02 |
membrane organization and biogenesis |
AmiGO Browser |
4.11 |
0.02 |
metabolic compound salvage |
AmiGO Browser |
50.57 |
0.02 |
regulation of cyclic nucleotide biosynthetic process |
AmiGO Browser |
44.95 |
0.02 |
regulation of cAMP metabolic process |
AmiGO Browser |
44.95 |
0.02 |
regulation of nucleotide biosynthetic process |
AmiGO Browser |
44.95 |
0.02 |
inner mitochondrial membrane organization and biogenesis |
AmiGO Browser |
40.45 |
0.02 |
regulation of protein modification |
AmiGO Browser |
40.45 |
0.02 |
negative regulation of nucleotide metabolic process |
AmiGO Browser |
40.45 |
0.02 |
purine ribonucleoside metabolic process |
AmiGO Browser |
40.45 |
0.02 |
purine nucleoside metabolic process |
AmiGO Browser |
40.45 |
0.02 |
positive regulation of cell projection organization and biogenesis |
AmiGO Browser |
40.45 |
0.02 |
cell cycle process |
AmiGO Browser |
2.48 |
0.03 |
positive regulation of hydrolase activity |
AmiGO Browser |
7.93 |
0.03 |
protein insertion into membrane |
AmiGO Browser |
36.78 |
0.03 |
caspase activation via cytochrome c |
AmiGO Browser |
36.78 |
0.03 |
protein import into mitochondrion |
AmiGO Browser |
36.78 |
0.03 |
regulation of cyclic nucleotide metabolic process |
AmiGO Browser |
36.78 |
0.03 |
regulation of growth |
AmiGO Browser |
4.63 |
0.03 |
organelle organization and biogenesis |
AmiGO Browser |
2.25 |
0.03 |
complement activation, alternative pathway |
AmiGO Browser |
33.71 |
0.03 |
DNA topological change |
AmiGO Browser |
33.71 |
0.03 |
negative regulation of survival gene product activity |
AmiGO Browser |
33.71 |
0.03 |
regulation of cell projection organization and biogenesis |
AmiGO Browser |
33.71 |
0.03 |
organelle fusion |
AmiGO Browser |
33.71 |
0.03 |
regulation of mitochondrial membrane potential |
AmiGO Browser |
33.71 |
0.03 |
T cell homeostasis |
AmiGO Browser |
33.71 |
0.03 |
ribonucleoside metabolic process |
AmiGO Browser |
33.71 |
0.03 |
regulation of nucleotide metabolic process |
AmiGO Browser |
31.12 |
0.03 |
chromosome organization and biogenesis (sensu Eukaryota) |
AmiGO Browser |
3.39 |
0.03 |
cell growth |
AmiGO Browser |
4.37 |
0.03 |
regulation of cell size |
AmiGO Browser |
4.30 |
0.03 |
mitosis |
AmiGO Browser |
4.27 |
0.03 |
chromosome organization and biogenesis |
AmiGO Browser |
3.28 |
0.04 |
M phase of mitotic cell cycle |
AmiGO Browser |
4.18 |
0.04 |
localization within membrane |
AmiGO Browser |
26.97 |
0.04 |
fibroblast proliferation |
AmiGO Browser |
26.97 |
0.04 |
regulation of fibroblast proliferation |
AmiGO Browser |
26.97 |
0.04 |
regulation of protein binding |
AmiGO Browser |
26.97 |
0.04 |
cell division |
AmiGO Browser |
4.09 |
0.04 |
cytolysis |
AmiGO Browser |
25.28 |
0.04 |
negative regulation of neuron apoptosis |
AmiGO Browser |
23.80 |
0.04 |
Wnt receptor signaling pathway, calcium modulating pathway |
AmiGO Browser |
22.47 |
0.04 |
patterning of blood vessels |
AmiGO Browser |
22.47 |
0.04 |
positive regulation of enzyme activity |
AmiGO Browser |
3.82 |
0.05 |
protein polyubiquitination |
AmiGO Browser |
21.29 |
0.05 |
lymphocyte homeostasis |
AmiGO Browser |
21.29 |
0.05 |
cell cycle |
AmiGO Browser |
2.17 |
0.05 |
vasoconstriction |
AmiGO Browser |
20.23 |
0.05 |
Wnt receptor signaling pathway |
AmiGO Browser |
5.58 |
0.05 |
homeostasis of number of cells |
AmiGO Browser |
19.26 |
0.05 |
regulation of survival gene product activity |
AmiGO Browser |
19.26 |
0.05 |
macrophage differentiation |
AmiGO Browser |
19.26 |
0.05 |
phospholipid transport |
AmiGO Browser |
19.26 |
0.05 |
leukocyte homeostasis |
AmiGO Browser |
19.26 |
0.05 |
release of cytochrome c from mitochondria |
AmiGO Browser |
18.39 |
0.05 |
cell structure disassembly during apoptosis |
AmiGO Browser |
18.39 |
0.05 |
apoptotic nuclear changes |
AmiGO Browser |
18.39 |
0.05 |
intracellular protein transport |
AmiGO Browser |
2.86 |
0.05 |
DNA duplex unwinding |
AmiGO Browser |
16.86 |
0.06 |
DNA unwinding during replication |
AmiGO Browser |
16.86 |
0.06 |
DNA geometric change |
AmiGO Browser |
16.86 |
0.06 |
regulation of biological quality |
AmiGO Browser |
2.43 |
0.06 |
DNA modification |
AmiGO Browser |
16.18 |
0.06 |
apoptotic mitochondrial changes |
AmiGO Browser |
15.56 |
0.06 |
response to toxin |
AmiGO Browser |
15.56 |
0.06 |
regulation of membrane potential |
AmiGO Browser |
15.56 |
0.06 |
establishment and/or maintenance of chromatin architecture |
AmiGO Browser |
3.32 |
0.06 |
B cell proliferation |
AmiGO Browser |
14.98 |
0.06 |
intra-Golgi vesicle-mediated transport |
AmiGO Browser |
14.98 |
0.06 |
male gonad development |
AmiGO Browser |
14.98 |
0.06 |
DNA packaging |
AmiGO Browser |
3.27 |
0.07 |
cAMP biosynthetic process |
AmiGO Browser |
14.45 |
0.07 |
protein targeting to mitochondrion |
AmiGO Browser |
13.95 |
0.07 |
mRNA splice site selection |
AmiGO Browser |
13.48 |
0.07 |
ribonucleoside monophosphate biosynthetic process |
AmiGO Browser |
13.48 |
0.07 |
regulation of neuron apoptosis |
AmiGO Browser |
13.48 |
0.07 |
ribonucleoside monophosphate metabolic process |
AmiGO Browser |
13.48 |
0.07 |
anatomical structure morphogenesis |
AmiGO Browser |
1.94 |
0.07 |
development of primary male sexual characteristics |
AmiGO Browser |
13.05 |
0.07 |
nucleotide biosynthetic process |
AmiGO Browser |
4.42 |
0.08 |
Golgi vesicle transport |
AmiGO Browser |
4.42 |
0.08 |
nucleoside monophosphate metabolic process |
AmiGO Browser |
12.64 |
0.08 |
phospholipase C activation |
AmiGO Browser |
12.64 |
0.08 |
nucleoside metabolic process |
AmiGO Browser |
12.64 |
0.08 |
nucleoside monophosphate biosynthetic process |
AmiGO Browser |
12.64 |
0.08 |
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
1.50 |
0.08 |
eye morphogenesis |
AmiGO Browser |
12.26 |
0.08 |
neural crest cell development |
AmiGO Browser |
12.26 |
0.08 |
neural crest cell differentiation |
AmiGO Browser |
12.26 |
0.08 |
growth |
AmiGO Browser |
3.01 |
0.08 |
vesicle-mediated transport |
AmiGO Browser |
2.47 |
0.08 |
protein homooligomerization |
AmiGO Browser |
11.56 |
0.08 |
complement activation, classical pathway |
AmiGO Browser |
11.24 |
0.09 |
establishment of protein localization |
AmiGO Browser |
2.16 |
0.09 |
cAMP metabolic process |
AmiGO Browser |
10.93 |
0.09 |
mitotic checkpoint |
AmiGO Browser |
10.93 |
0.09 |
mitotic cell cycle |
AmiGO Browser |
2.88 |
0.09 |
glucose transport |
AmiGO Browser |
10.65 |
0.09 |
mesenchymal cell development |
AmiGO Browser |
10.65 |
0.09 |
humoral immune response mediated by circulating immunoglobulin |
AmiGO Browser |
10.65 |
0.09 |
mesenchymal cell differentiation |
AmiGO Browser |
10.37 |
0.09 |
cytokinesis |
AmiGO Browser |
10.11 |
0.09 |
hexose transport |
AmiGO Browser |
10.11 |
0.09 |
G1 phase |
AmiGO Browser |
10.11 |
0.09 |
monosaccharide transport |
AmiGO Browser |
10.11 |
0.09 |
male sex differentiation |
AmiGO Browser |
9.87 |
0.10 |
embryonic pattern specification |
AmiGO Browser |
9.87 |
0.10 |
regulation of binding |
AmiGO Browser |
9.87 |
0.10 |
nuclear organization and biogenesis |
AmiGO Browser |
9.63 |
0.10 |
neuron apoptosis |
AmiGO Browser |
9.63 |
0.10 |
cellular component organization and biogenesis |
AmiGO Browser |
1.50 |
0.10 |
regulation of blood vessel size |
AmiGO Browser |
9.41 |
0.10 |
cyclic nucleotide biosynthetic process |
AmiGO Browser |
9.41 |
0.10 |
response to hypoxia |
AmiGO Browser |
9.41 |
0.10 |
activation of plasma proteins during acute inflammatory response |
AmiGO Browser |
9.19 |
0.10 |
complement activation |
AmiGO Browser |
9.19 |
0.10 |
protein localization |
AmiGO Browser |
2.03 |
0.10 |